搜索结果: 1-15 共查到“肿瘤病理学 Research”相关记录15条 . 查询时间(0.14 秒)
2020年12月4日，基础医学院病理学系韩博教授课题组最新研究成果“KIF15-mediated stabilization of AR and AR-V7 contributes to enzalutamide resistance in prostate cancer”（KIF15介导的AR和AR-V7蛋白稳定性促进前列腺癌细胞对恩杂鲁胺耐药）在国际权威肿瘤学期刊Cancer Research...
浙江大学基础医学院应颂敏、沈华浩教授团队Cell Research发文揭示肿瘤基因组普通脆性位点序列图谱（图）
浙江大学基础医学院 应颂敏 沈华浩教授团队 Cell Research 肿瘤基因组 普通脆性位点序列 图谱
2020/6/23
人类细胞的每一次增殖和分裂，都伴随着全基因组DNA的精确复制。然而，在快速分裂的肿瘤细胞中，DNA复制常常会发生问题，导致染色体产生缺口或断裂。半个世纪前，人们就观察到肿瘤细胞的染色体容易断裂，且常常发生在一些固定的保守区域，被称为普通脆性位点（Common Fragile Sites)。在复制压力存在情况下，普通脆性位点处易发生染色体重排和基因拷贝数变异，造成基因组不稳定。脆性位点的“脆性”导致...
河南大学生命科学学院王彦明课题组在Molecular Cancer Research杂志发表关于PAD4调控肿瘤生长与转移的最新研究（图）
河南大学生命科学学院 王彦明 Molecular Cancer Research 肿瘤转移 PAD4 乳腺癌
2020/3/30
2020年3月19日，河南大学生命科学学院王彦明教授课题组及合作者在肿瘤转移领域取得重要进展，在国际上首次揭示组蛋白瓜氨酸化可在肿瘤细胞中解聚染色体并导致细胞外染色质丝的形成。而催化瓜氨酸化并在肿瘤组织中高表达的蛋白质肽基精氨酸脱氨酶4(PAD4)对促进肿瘤生长及转移发挥着重要作用。该研究成果以“Endogenous PAD4 in Breast Cancer Cells Mediates Can...
华南理工大学医学院温龙平教授团队在Accounts of Chemical Research发表邀请综述（图）
华南理工大学医学院 温龙平 教授 Accounts of Chemical Research 综述
2019/11/29
近日，华南理工大学医学院、生命科学研究院温龙平教授和张云娇副教授受邀在国际顶级期刊《Accounts of Chemical Research》（影响因子21.661）发表题为《Pro-Death or Pro-Survival: Contrasting Paradigms on Nanomaterial-Induced Autophagy and Exploitations for Cancer...
近期，国际知名学术期刊、美国癌症协会会刊《Cancer Research》在线发表了实验室与天津医科大学医学院、上海交通大学医学院有关“肺癌肿瘤代谢调控研究”的合作研究成果：“PAK4 phosphorylates fumarase and blocks TGF-β-induced cell growth arrest in lung cancer cells”。研究阐明了转化生长因子β（TGF-...
中山大学附属第一医院柯尊富主任医师团队在Clinical Cancer Research期刊发表驱动基因阴性肺腺癌研究成果（图）
中山大学附属第一医院 柯尊富 主任医师 驱动基因 阴性 肺腺癌 研究成果
2018/12/4
2018年11月3日，我校附属第一医院病理科柯尊富主任医师肺癌研究团队在Clinical Cancer Research (IF 2017=10.19）期刊上发表了研究性论文Development and validation of a novel signature to predict overall survival in “driver-gene-negative” lung adenoc...
2017年癌症纳米技术高登研究研讨会（The Gordon Research Seminar on Cancer Nanotechnology）
Cancer Nanotechnology controller algorithms
2017/3/7
Applications for this meeting must be submitted by May 20, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be st...
北京大学生物动态光学成像中心（BIOPIC）苏晓东研究组与北京天坛医院江涛研究组以及加州大学圣地亚哥分校的Clark Chen研究组合作在Genome Research杂志在线发表了题为“RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas...
University of Queensland Researchers and Pathology Queensland have found women under 50 with breast cancer are more likely to develop secondary cancer in the liver or gynaecological organs.
The University of Queensland Diamantina Institute has secured a $2 million grant from the Australian Cancer Research Foundation for a new cancer treatment centre in Brisbane.
Queensland, Emory research alliance targets cancer treatments（图）
cancer treatments breast cancer
2014/7/10
A collaborative research project aimed at discovering a drug to treat a highly resistant form of breast cancer is one of two projects given the green light by the Queensland Emory Development (QED) Al...
Janet Rowley to receive AACR award for lifetime achievement in cancer research（图）
Janet Rowley AACR award cancer research
2010/4/29
Janet Rowley, the Blum-Riese Distinguished Service Professor in Medicine, Molecular Genetics and Cell Biology, and Human Genetics, will receive the seventh annual American Association for Cancer Resea...
Cancer research has traditionally been the realm of biologists, and, more recently, engineers. Now, physicists are getting in on the action.MIT has been awarded a five-year grant from the National Can...
Maximising opportunities for clinical research: The Centre for Developmental Cancer Therapeutics
clinical research Maximising opportunities
2015/3/13
Clinical research provides laboratory scientists, translational
scientists, clinicians and patients with the opportunity to
participate in the evaluation of novel therapeutics. However, a
significa...
Cancer Trials NSW: A collaborative initiative to support and promote cancer clinical trials research in NSW
Cancer Trials NSW cancer
2015/3/13
People with cancer who are treated in clinical trials are more
satisfied and do better than people who receive the same
treatment outside of a clinical trial. Despite this, less than 3%
of NSW adul...